Diving deep into uterine layers: ADC and IVIM at 0.55-T MRI

OBJECTIVE: To investigate and analyze the microstructure of uterine layers and to evaluate the feasibility and physiological variability of uterine diffusion metrics at 0.55-T MRI in healthy volunteers and participants with adenomyosis. MATERIALS AND METHODS: In this prospective study, 106 women, including healthy controls without (n = 47) and with hormonal contraception (n = 37), and patients diagnosed with adenomyosis (n = 22), underwent uterine diffusion MRI at 0.55 T. Apparent diffusion coefficient (ADC) and intravoxel incoherent motion (IVIM) were modeled using nine b-values in the myometrium, junctional zone, and endometrium. Quantitative intergroup differences, intragroup comparisons, and anterior-posterior wall analyses were performed. Evaluation of scan repetitions, intra-annotator and inter-annotator variability, and IVIM fit quality assessments were performed in subcohorts. RESULTS: The intergroup analysis was performed on 106 women aged 27.2 ± 5.9 years (mean ± standard deviation) without bowel preparation or antispasmodics. A reduced median myometrium ADC (p = 0.024), reduced endometrial mean diffusivity (p = 0.017), and increased perfusion fraction (p = 0.014) were observed in the cohort with adenomyosis compared to healthy volunteers. Interindividual and intra-individual analysis of healthy volunteers demonstrated increased diffusivity in the endometrium during the luteal phase (p = 0.024). Additionally, differences in diffusion and IVIM parameters were observed in adenomyosis participants undergoing hormonal therapy. Repeat measurements, intra-annotator and inter-annotator agreement, and IVIM metric stability demonstrated good consistency. CONCLUSION: This study provides early evidence that uterine diffusion and IVIM at 0.55 T enable robust, non-invasive characterization of uterine microstructure sensitive to menstrual phase, hormonal status, and adenomyosis, providing insight into uterine physiology and pathology. KEY POINTS: Question Can 0.55-T MRI characterize functional changes associated with adenomyosis compared with healthy uteri? Findings 0.55-T uterine diffusion MRI without bowel preparation quantified uterine microstructure, with layer-specific ADC and IVIM distinguishing adenomyosis, hormonal effects, menstrual phase, and anterior-posterior differences. Relevance statement Quantitative diffusion and IVIM metrics at 0.55-T distinguish adenomyosis from healthy tissue through reduced myometrial ADC, endometrial diffusivity, and increased perfusion fraction. These biomarkers hold promise in clarifying diagnosis and supporting future studies assessing hormonal therapy response and treatment monitoring.

Authors

Institutions

Publication Details

Journal
European Radiology Experimental
Published
2026-09-17
DOI
https://doi.org/10.1186/s41747-026-00815-x
Primary Topic
Endometriosis Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Diving deep into uterine layers: ADC and IVIM at 0.55-T MRI

Katharina Breininger, Maximilian Lindholz, Milauni Desai, Smiti Tripathy et al.
European Radiology Experimental
Endometriosis Research and Treatment
article

Diving deep into uterine layers: ADC and IVIM at 0.55-T MRI

Katharina Breininger, Maximilian Lindholz, Milauni Desai, Smiti Tripathy, Lieselotte Kratzsch, Jana Hutter, Franziska Mathis-Ullrich, Vignesh V. Pai
article en

Abstract

OBJECTIVE: To investigate and analyze the microstructure of uterine layers and to evaluate the feasibility and physiological variability of uterine diffusion metrics at 0.55-T MRI in healthy volunteers and participants with adenomyosis. MATERIALS AND METHODS: In this prospective study, 106 women, including healthy controls without (n = 47) and with hormonal contraception (n = 37), and patients diagnosed with adenomyosis (n = 22), underwent uterine diffusion MRI at 0.55 T. Apparent diffusion coefficient (ADC) and intravoxel incoherent motion (IVIM) were modeled using nine b-values in the myometrium, junctional zone, and endometrium. Quantitative intergroup differences, intragroup comparisons, and anterior-posterior wall analyses were performed. Evaluation of scan repetitions, intra-annotator and inter-annotator variability, and IVIM fit quality assessments were performed in subcohorts. RESULTS: The intergroup analysis was performed on 106 women aged 27.2 ± 5.9 years (mean ± standard deviation) without bowel preparation or antispasmodics. A reduced median myometrium ADC (p = 0.024), reduced endometrial mean diffusivity (p = 0.017), and increased perfusion fraction (p = 0.014) were observed in the cohort with adenomyosis compared to healthy volunteers. Interindividual and intra-individual analysis of healthy volunteers demonstrated increased diffusivity in the endometrium during the luteal phase (p = 0.024). Additionally, differences in diffusion and IVIM parameters were observed in adenomyosis participants undergoing hormonal therapy. Repeat measurements, intra-annotator and inter-annotator agreement, and IVIM metric stability demonstrated good consistency. CONCLUSION: This study provides early evidence that uterine diffusion and IVIM at 0.55 T enable robust, non-invasive characterization of uterine microstructure sensitive to menstrual phase, hormonal status, and adenomyosis, providing insight into uterine physiology and pathology. KEY POINTS: Question Can 0.55-T MRI characterize functional changes associated with adenomyosis compared with healthy uteri? Findings 0.55-T uterine diffusion MRI without bowel preparation quantified uterine microstructure, with layer-specific ADC and IVIM distinguishing adenomyosis, hormonal effects, menstrual phase, and anterior-posterior differences. Relevance statement Quantitative diffusion and IVIM metrics at 0.55-T distinguish adenomyosis from healthy tissue through reduced myometrial ADC, endometrial diffusivity, and increased perfusion fraction. These biomarkers hold promise in clarifying diagnosis and supporting future studies assessing hormonal therapy response and treatment monitoring.

European Radiology ExperimentalVol. 10(1)
Leibniz University Hannover (DE), Friedrich-Alexander-Universität Erlangen-Nürnberg (DE), University of Würzburg (DE), Universitätsklinikum Erlangen (DE), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), Charité - Universitätsmedizin Berlin (DE)
Deutsche Forschungsgemeinschaft, European Research Council
Good health and well-being
Openalex Percentile: Top 9%
Endometriosis Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.